MedAvail (MDVLQ) 10-Q2019 Q1 Quarterly report

Filed: 8 May 19, 5:00pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: ACL, anorexia, anterior, anticipate, attenuating, augment, biological, borrowing, Cer, circumference, clarification, clarify, conversion, converted, copier, cumulative, DACVIM, decided, dedicated, dismissal, dismissed, disuse, dog, domestic, drew, DVM, entirety, equipment, escalating, estate, exceeded, facility, feet, filled, final, force, Fortetropin®at, frequently, geriatric, goodwill, Hanover, Harkin, Head, immobilized, implicit, inception, innovative, Kenneth, Licensing, limb, matter, MCMF, midpoint, mismanaged, nineteen, noncancellable, Orlando, orthopedic, practical, predict, prosecution, randomly, rapid, recovery, relevant, rodent, ROU, SAIM, sharesin, Simplifying, size, sought, space, square, stance, step, Stipulation, superseded, surgical, tain, thigh, titled, Township, unaffected, Vetrax, VMX, worn, Yolked®product

Removed: addressing, adjourn, affiliate, aforementioned, announced, antidilutive, area, asserted, autoimmune, binding, bionutrition, biotherapeutic, carried, carryback, Cedar, certification, China, chronic, codified, combination, concurrent, consent, constituent, consulting, coordinate, created, Cut, Cutler, cytokine, deemed, deficiency, degenerative, denervation, depend, deposit, detected, dietary, discovered, disease, drug, education, eighty, elucidate, enforceable, enhanced, entry, expert, expiring, failed, finance, Fortetropin®, Fortetropin®that, Fortetropin®to, foundation, generated, generation, gram, grossly, HealthTM, IFN, immobility, impart, indefinitely, inflammation, inflammatory, institutional, insufficient, introduced, investor, key, Lab, lack, lead, legally, lessee, lifestyle, lt, managing, master, meal, methodology, misstatement, modulation, negligent, NOL, October, partially, patented, patient, periodic, petition, plethora, population, powder, proactively, promoted, provision, rational, receiving, referencing, released, remediated, remediating, renew, rental, repairing, replacement, reserved, restate, revoked, screening, secondary, segregation, serving, shareholder, shipped, signature, Sport, statutory, stratification, submitted, subsequent, suffering, Superior, supplement, supplementing, telephone, temporarily, terminated, treating, uncertainty, unilateral, unrecognized, utilization, website

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated MDVLQ transcripts

MDVLQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of MYOS RENS Technology Inc. (the “Company”) for the quarter ended March 31, 2019, (the “Report”), I, Joseph Mannello, the Principal Executive Officer and the Principal Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 8, 2019

By:	/s/ Joseph Mannello
Name:	Joseph Mannello
Title:	Chief Executive Officer
	(Principal Executive Officer and Principal Financial Officer)

This certification accompanies this report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purpose of Section 18 of the Securities Exchange Act of 1934, as amended.